Philip Morris International (PM) is seeing changes in its share positions with multiple firms buying and selling their stakes. Firms like Blue Trust Inc. and QRG Capital Management. are increasing their position in PM while others such as Hendley & Co. Inc. and State of Alaska Department of Revenue are lowering theirs. The company continues with its effort to establish its IQOS product as a reduced risk option in the market, seeking FDA approval for this claim. PM's U.S. investment in smoke-free products has been noted, pointing towards a potential long-term growth strategy. The company also urges the FDA to recommend the continued marketing of IQOS as a modified risk product. Despite some shares being sold, Weiss Ratings reaffirms its buy rating for PM. Amidst trade uncertainty, PM appears in an upward trend and is looking appealing for long-term growth. It's shown resilience with its strengthened US manufacturing and smoke-free progress. However, there are some concerns as PM's sales have missed estimates and profit guidance is slightly below expectations.
Philip Morris International PM News Analytics from Wed, 11 Jun 2025 07:00:00 GMT to Sat, 11 Oct 2025 11:51:27 GMT -
Rating 4
- Innovation 2
- Information 6
- Rumor -4
